The Phase 3 trial results are out, and Retatrutide is seriously a miracle drug.

Significant Weight Loss with 12mg Dosage
• A 28.3% reduction in body weight was observed over 80 weeks with a 12mg dosage.
• This equates to an average weight loss of 70.3 pounds (31.9 kg).
• Notably, 45.3% of patients achieved a weight loss exceeding 30%, a level comparable to outcomes typically seen with bariatric surgery.
• For patients with higher baseline BMIs, a 30.3% weight loss (85 lbs) was recorded at 104 weeks.
• Furthermore, 65.3% of patients receiving the 12mg dosage transitioned below the obesity BMI threshold.

Efficacy and Tolerability of 4mg Dosage
• With a 4mg dosage over 80 weeks, a 19% weight loss (47.2 lbs) was achieved, accompanied by a lower dropout rate compared to the placebo group (4.1% vs 4.9%).

Metabolic Health and Safety Profile
• Significant improvements were also noted in blood pressure, triglycerides, non-HDL cholesterol, waist circumference, and hsCRP levels.
• No adverse cardiac or hepatic signals were detected.

Retatrutide’s going to be the next Ozempic when it’s prescribed to the public.